BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17878805)

  • 21. Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease.
    Damon-Perriere N; Menegon P; Olivier A; Boespflug-Tanguy O; Niel F; Creveaux I; Dousset V; Brochet B; Goizet C
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1068-71. PubMed ID: 18845387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation.
    Fogli A; Dionisi-Vici C; Deodato F; Bartuli A; Boespflug-Tanguy O; Bertini E
    Neurology; 2002 Dec; 59(12):1966-8. PubMed ID: 12499492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exon deletion in the non-catalytic domain of eIF2Bepsilon due to a splice site mutation leads to infantile forms of CACH/VWM with severe decrease of eIF2B GEF activity.
    Horzinski L; Gonthier C; Rodriguez D; Scherer C; Boespflug-Tanguy O; Fogli A
    Ann Hum Genet; 2008 May; 72(Pt 3):410-5. PubMed ID: 18294360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity.
    Richardson JP; Mohammad SS; Pavitt GD
    Mol Cell Biol; 2004 Mar; 24(6):2352-63. PubMed ID: 14993275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease.
    de Almeida RA; Fogli A; Gaillard M; Scheper GC; Boesflug-Tanguy O; Pavitt GD
    PLoS One; 2013; 8(1):e53958. PubMed ID: 23335982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ovarioleukodystrophy.
    Mathis S; Scheper GC; Baumann N; Petit E; Gil R; van der Knaap MS; Neau JP
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1035-7. PubMed ID: 18678442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukoencephalopathy with vanishing white matter: a review.
    Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS
    J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease].
    Kashiwagi K; Ito T; Yokoyama S
    Brain Nerve; 2017 Jan; 69(1):45-50. PubMed ID: 28126977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and clinical heterogeneity in eIF2B-related disorder.
    Maletkovic J; Schiffmann R; Gorospe JR; Gordon ES; Mintz M; Hoffman EP; Alper G; Lynch DR; Singhal BS; Harding C; Amartino H; Brown CM; Chan A; Renaud D; Geraghty M; Jensen L; Senbil N; Kadom N; Nazarian J; Yuanjian Feng ; Zuyi Wang ; Hartka T; Morizono H; Vanderver A
    J Child Neurol; 2008 Feb; 23(2):205-15. PubMed ID: 18263758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EIF2B2 gene mutation causing early onset vanishing white matter disease: a case report.
    Filareto I; Cinelli G; Scalabrini I; Caramaschi E; Bergonzini P; Spezia E; Todeschini A; Iughetti L
    Ital J Pediatr; 2022 Jul; 48(1):128. PubMed ID: 35897042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up.
    Bektaş G; Yeşil G; Özkan MU; Yıldız EP; Uzunhan TA; Çalışkan M
    Clin Neurol Neurosurg; 2018 Aug; 171():190-193. PubMed ID: 29933199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarioleukodystrophy due to EIF2B5 mutations.
    Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
    Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.
    van der Knaap MS; Leegwater PA; Könst AA; Visser A; Naidu S; Oudejans CB; Schutgens RB; Pronk JC
    Ann Neurol; 2002 Feb; 51(2):264-70. PubMed ID: 11835386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease.
    van Kollenburg B; van Dijk J; Garbern J; Thomas AA; Scheper GC; Powers JM; van der Knaap MS
    J Neuropathol Exp Neurol; 2006 Jul; 65(7):707-15. PubMed ID: 16825957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutation in EIF2B gene in a case of adult-onset leukoencephalopathy with vanishing white matter.
    Matsui M; Mizutani K; Ohtake H; Miki Y; Ishizu K; Fukuyama H; Shimohata T; Onodera O; Nishizawa M; Takayama Y; Shibasaki H
    Eur Neurol; 2007; 57(1):57-8. PubMed ID: 17119336
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficient detection of frequent eIF2B mutations for the rapid molecular diagnosis of CACH/VWM syndrome.
    Ferreira MC; Dorboz I; Boespflug-Tanguy O
    Clin Biochem; 2015 Dec; 48(18):1317-23. PubMed ID: 26162493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].
    Pan YX; Wu Y; Niu ZP; Jiang YW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.
    Mao D; Reuter CM; Ruzhnikov MRZ; Beck AE; Farrow EG; Emrick LT; Rosenfeld JA; Mackenzie KM; Robak L; Wheeler MT; Burrage LC; Jain M; Liu P; Calame D; Küry S; Sillesen M; Schmitz-Abe K; Tonduti D; Spaccini L; Iascone M; Genetti CA; Koenig MK; Graf M; Tran A; Alejandro M; ; Lee BH; Thiffault I; Agrawal PB; Bernstein JA; Bellen HJ; Chao HT
    Am J Hum Genet; 2020 Apr; 106(4):570-583. PubMed ID: 32197074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
    Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
    Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vanishing white matter disease associated with progressive macrocephaly.
    Pineda M; R-Palmero A; Baquero M; O'Callaghan M; Aracil A; van der Knaap M; Scheper GC
    Neuropediatrics; 2008 Feb; 39(1):29-32. PubMed ID: 18504679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.